Caris Life Sciences (CAI) Receivables - Other (2024 - 2025)
Caris Life Sciences (CAI) has 2 years of Receivables - Other data on record, last reported at $7.2 million in Q4 2025.
- For Q4 2025, Receivables - Other rose 56.52% year-over-year to $7.2 million; the TTM value through Dec 2025 reached $7.2 million, up 56.52%, while the annual FY2025 figure was $7.2 million, 56.52% up from the prior year.
- Receivables - Other reached $7.2 million in Q4 2025 per CAI's latest filing, down from $9.9 million in the prior quarter.
- Across five years, Receivables - Other topped out at $11.2 million in Q2 2025 and bottomed at $4.6 million in Q4 2024.